Search

everythinglearnresearchcommunity

for

Search:↓

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Tacrolimus ointment is effective for various skin conditions but needs more research for long-term effects.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Clofazimine effectively treated ashy dermatosis in a patient.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Systemic steroids can effectively treat alopecia areata with manageable side effects.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Etanercept effectively treated a severe skin condition when other treatments failed.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.